Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 5,788 shares at $42.45 ($249K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $249k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.45 | 2,363 | $100K | 40.4% |
| 2 | $43.20 | 3,051 | $132K | 53.0% |
| 3 | $43.94 | 374 | $16K | 6.6% |
| Total | $42.94 avg | 5,788 | $249K | 100% |
| Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $196K | — | Filing → |